|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Al-Sarraf M, LeBlanc M, Giri PG, Fu KK,
Cooper J, Vuong T, Forastiere AA, Adams G, Sakr WA, Schuller DE and
Ensley JF: Chemoradiotherapy versus radiotherapy in patients with
advanced nasopharyngeal cancer: Phase III randomized Intergroup
study 0099. J Clin Oncol. 16:1310–1317. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bensouda Y, Kaikani W, Ahbeddou N, Rahhali
R, Jabri M, Mrabti H, Boussen H and Errihani H: Treatment for
metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head
Neck Dis. 128:79–85. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaufmann SH and Earnshaw WC: Induction of
apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allison AC, Cacabelos R, Lombardi VR,
Alvarez XA and Vigo C: Celastrol, a potent antioxidant and
anti-inflammatory drug, as a possible treatment for Alzheimer's
disease. Prog Neuropsychopharmacol Biol Psychiatry. 25:1341–1357.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ji N, Li J, Wei Z, Kong F, Jin H, Chen X,
Li Y and Deng Y: Effect of celastrol on growth inhibition of
prostate cancer cells through the regulation of hERG channel in
vitro. Biomed Res Int. 2015:3084752015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH
and Chun KH: Celastrol inhibits gastric cancer growth by induction
of apoptosis and autophagy. BMB Rep. 47:697–702. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li PP, He W, Yuan PF, Song SS, Lu JT and
Wei W: Celastrol induces mitochondria-mediated apoptosis in
hepatocellular carcinoma Bel-7402 cells. Am J Chin Med. 43:137–148.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shrivastava S, Jeengar MK, Reddy VS, Reddy
GB and Naidu VG: Anticancer effect of celastrol on human triple
negative breast cancer: Possible involvement of oxidative stress,
mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Exp Mol
Pathol. 98:313–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu J and Wu CL: Anti-metastasis of
celastrol on esophageal cancer cells and its mechanism. Sheng Li
Xue Bao. 67:341–347. 2015.(In Chinese). PubMed/NCBI
|
|
12
|
Xu J, Wu CL and Huang J: Effect of
celastrol in inhibiting metastasis of lung cancer cells by
influencing Akt signaling pathway and expressing integrins.
Zhongguo Zhong Yao Za Zhi. 40:1129–1133. 2015.(In Chinese).
PubMed/NCBI
|
|
13
|
Yu X, Zhou X, Fu C, Wang Q, Nie T, Zou F,
Guo R, Liu H, Zhang B and Dai M: Celastrol induces apoptosis of
human osteosarcoma cells via the mitochondrial apoptotic pathway.
Oncol Rep. 34:1129–1136. 2015.PubMed/NCBI
|
|
14
|
Chen T and Wong YS: Selenocystine induces
S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7
cells by modulating ERK and Akt phosphorylation. J Agric Food Chem.
56:10574–10581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G
and Zhang D: HSP90 inhibitor, celastrol, arrests human monocytic
leukemia cell U937 at G0/G1 in thiol-containing agents reversible
way. Mol Cancer. 9:792010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rajendran P, Li F, Shanmugam MK, Kannaiyan
R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, et al:
Celastrol suppresses growth and induces apoptosis of human
hepatocellular carcinoma through the modulation of STAT3/JAK2
signaling cascade in vitro and in vivo. Cancer Prev Res (Phila).
5:631–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang WB, Feng LX, Yue QX, Wu WY, Guan SH,
Jiang BH, Yang M, Liu X and Guo DA: Paraptosis accompanied by
autophagy and apoptosis was induced by celastrol, a natural
compound with influence on proteasome, ER stress and Hsp90. J Cell
Physiol. 227:2196–2206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anilkumar U and Prehn JH: Anti-apoptotic
BCL-2 family proteins in acute neural injury. Front Cell Neurosci.
8:2812014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Primikyri A, Chatziathanasiadou MV, Karali
E, Kostaras E, Mantzaris MD, Hatzimichael E, Shin JS, Chi SW,
Briasoulis E, Kolettas E, et al: Direct binding of Bcl-2 family
proteins by quercetin triggers its pro-apoptotic activity. ACS Chem
Biol. 9:2737–2741. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu
W, He QJ and Yang B: Up-regulation of death receptor 4 and 5 by
celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. Cancer
Lett. 297:155–164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Choi BS, Kim H, Lee HJ, Sapkota K, Park
SE, Kim S and Kim SJ: Celastrol from ‘Thunder God Vine’ protects
SH-SY5Y cells through the preservation of mitochondrial function
and inhibition of p38 MAPK in a rotenone model of Parkinson's
disease. Neurochem Res. 39:84–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
